Evidence map›Paper›PMID 42221051›Full record

ReviewJAC-antimicrobial resistance2026

Governance of antimicrobial resistance in Central Africa (2015-2025): a systematic review of policies, One Health coordination and funding.

Gabriel Tchuente Kamsu, Ingrid Cécile Djuikoue, Benjamin D Thumamo Pokam, Cedric Dylan Seugnou Nana, Clement Ngandjui Yonga, Mallila Georgia Mboupaing, Marie Stella Marehin, Nicole Prisca Makaya Danguil Nieko, Flambel Sanou Kue, Tatiana Banze Mewehu and 6 more

Abstract readReview
In one paragraph

Review in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Gabriel Tchuente KamsuCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.ORCID https://orcid.org/0000-0001-5641-5916
Ingrid Cécile DjuikoueCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.ORCID https://orcid.org/0000-0001-9615-8950
Benjamin D Thumamo PokamCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.
Cedric Dylan Seugnou NanaCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.
Clement Ngandjui YongaCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.ORCID https://orcid.org/0009-0006-9969-1017
Mallila Georgia MboupaingCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.
Marie Stella MarehinCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.
Nicole Prisca Makaya Danguil NiekoCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.
Flambel Sanou KueCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.
Tatiana Banze MewehuCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.
Dorine TseukoCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.
Siapsantos HironiCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.
Marie Therese MboliyouCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.
Rita Armelle Gatse BouyaCentral African Network for the Integrated Control of Antimicrobial Resistance (CANIC-AMR), Yaoundé, Cameroun.
Teke Ruffin ApalataFaculty of Medicine and Health Sciences, Walter Sisulu University, Mthatha, South Africa.
Nicolas Antoine-MoussiauxDépartement des Sciences de la Santé Publique, Faculté de Médecine, Université de Liège, Liège, Belgique.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Antimicrobial resistance (AMR) poses a major threat to effective treatment and global health security, with disproportionate impacts in low- and middle-income settings. In Central Africa, health system fragility, limited surveillance capacity and weak multisectoral coordination heighten vulnerability. Despite momentum following the WHO Global Action Plan, the status of AMR governance, One Health coordination and financing in the subregion remains insufficiently characterized. Objectives: To systematically assess AMR governance in Central Africa (2015-2025), focusing on policy frameworks, One Health coordination and financing mechanisms. Methods: We conducted a PRISMA 2020-compliant systematic review registered in PROSPERO (CRD420251082393). Six databases were searched, along with grey literature, including national policy documents, institutional reports and consultations with AMR focal points. Eligible sources addressed AMR policy, coordination, surveillance and funding. Results: Of the 4464 records identified, 27 documents were included (19 peer-reviewed articles, one report, seven national action plans). Evidence was concentrated in Cameroon, with limited data from other countries. National action plans aligned with global standards were identified in six countries, while none were available for Equatorial Guinea or the Republic of Congo. Across the region, governance was characterized by partial policy alignment but weak implementation, limited operationalization of One Health, fragmented surveillance and reliance on external funding. Key constraints included inadequate laboratory capacity, weak stewardship systems and insufficient domestic financing. Conclusion: AMR governance in Central Africa has progressed at the policy level but remains operationally constrained. Bridging the gap between policy and implementation requires strengthened institutionalization of One Health, improved accountability and sustainable domestic investment.

Identifiers

PMID42221051
PMCPMC13221972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.